SCHEMBL3624019

SCHEMBL3624019

CCCC[Sn](CCCC)(CCCC)c1cc(-c2cn3cc(OC)ccc3n2)ccc1OCCF

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A3 P47895 6/20 0.44
APP P05067 1/20 0.43
HRH3 Q9Y5N1 5/20 0.43
ALDH1A1 P00352 5/20 0.43
RAB9A P51151 5/20 0.43
SMN1; SMN2 Q16637 5/20 0.43
NPC1 O15118 4/20 0.43
MAPT P10636 4/20 0.43
LMNA P02545 2/20 0.43
KDM4E B2RXH2 4/20 0.42
HPGD P15428 3/20 0.41
NFKB1 P19838 2/20 0.41
NFKB2 Q00653 2/20 0.41
RELA Q04206 2/20 0.41
HSD17B10 Q99714 2/20 0.41
TP53 P04637 1/20 0.41
PKM P14618 1/20 0.41
ALOX15 P16050 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3629405 0.96 ALDH1A3 (0.44) ALDH1A3APPHRH3ALDH1A1RAB9A
SCHEMBL3622542 0.82 RAB9A (0.49) ALDH1A3HRH3ALDH1A1RAB9ASMN1; SMN2
SCHEMBL3627471 0.80 ALDH1A3 (0.51) ALDH1A3APPHRH3ALDH1A1RAB9A
SCHEMBL2903885 0.78 APP (0.57) ALDH1A3APPHRH3ALDH1A1RAB9A
SCHEMBL3627422 0.77 ALDH1A3 (0.50) ALDH1A3APPHRH3ALDH1A1RAB9A
SCHEMBL1726212 0.77 HRH3 (0.56) ALDH1A3HRH3ALDH1A1RAB9ASMN1; SMN2
SCHEMBL2817233 0.77 APP (0.62) ALDH1A3APPHRH3ALDH1A1RAB9A
SCHEMBL12855179 0.76 HRH3 (0.68) ALDH1A3APPHRH3ALDH1A1RAB9A
SCHEMBL3301661 0.74 APP (0.61) ALDH1A3APPHRH3ALDH1A1RAB9A
SCHEMBL2904661 0.73 ALDH1A3 (0.60) ALDH1A3APPHRH3ALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8399672-B2 Compound having affinity for amyloid NIHON MEDI-PHYSICS CO., LTD. (JP) 2013-03-19 US disclosed
US-20100292479-A1 NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID NIHON MEDI-PHYSICS CO., LTD. (JP) 2010-11-18 US disclosed
EP-2213671-A1 NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID Nihon Medi-Physics Co., Ltd. (JP) 2010-08-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100292479-A1 NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID APP, APBA1, BACE1 ALDH1A3 3022/4885APP 1/4885HRH3 12/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.